Delivery Order SPE2DB24D2101-SPE2DB25FKMWR
- Not listed
- The Defense Logistics Agency awarded a $1,687.48 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for ProQuad vials with a completion date of August 29, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's established relationships with DLA for pharmaceutical supply to...
- The Defense Logistics Agency (DLA) awarded a $1,687.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 19, 2025, with a completion date of September 10, 2025. This non-set-aside competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of ProQuad vials valued at $13,234.64 with a completion date of August 11, 2025. This non-competitive delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $2,740.40 with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.90 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,480.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of ProQuad vials, a combination vaccine product. This firm fixed price delivery order, valued at $6,405.01, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is non-set-aside and was competitively awarded, with performance to be completed by August 20, 2025, at AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a $16,543.30 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, a combination vaccine product, with a completion date of August 21, 2025. This competitive award (no set-aside used) was issued under a firm fixed-price structure and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,372.90 to AmerisourceBergen Drug Corp for ProQuad vials on July 24, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMWRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,374.88 to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated consistent capability in supplying pharmaceutical products and medical supplies to defense and veteran healthcare systems. This delivery order for ProQuad vials—a combination vaccine product—exemplifies the company's role in supporting military healthcare procurement through the DLA's pharmaceutical supply chain. The award reflects the company's standing as a competitively selected vendor capable of meeting federal medical supply requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/29/25 |